Patients with advanced heart failure can benefit from stem cell therapy, a large, new clinical trial has found.
Injections of stem cells programmed to heal damaged heart tissue wound up improving overall quality of life for heart failure patients, compared to those who received a placebo treatment.
“Data from one of the largest cardiovascular cell therapy trials, testing a regenerative technology discovered at Mayo Clinic, indicate benefit in both quantity and quality of life in advanced heart disease,” said researcher Dr. Satsuki Yamada, a Mayo Clinic heart doctor.
